Predictive value of antiphospholipid antibodies in hospitalized patients with potential thrombus risk

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045122

Enrollment

Unknown

Registered

2021-04-07

Start date

2021-04-12

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombotic disease

Interventions

Gold Standard:Clinical outcome

Index test:Antiphospholipid&#32

antibodies

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. At high risk of thrombosis assessed by professional clinicians of our hospital; 3. With complete hospitalization data and medical records; 4. Agree to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant woman; 2. A clear history of thrombotic disease in the past; 3. Concomitant with infectious diseases or malignant tumors; 4. Cognitive impairment or inability to collect biological samples or inability to complete appropriate follow-up.

Design outcomes

Primary

Measure	Time frame
lupus anticoagulant;anticardiolipin;anti- ß2-glycoprotein I antibodies;Sensitivity, specificity, accuracy, area under the curve, positive predictive value, negative predictive value;	—

Countries

China

Contacts

Public ContactZhang Bolin

Department of Laboratory Medicine, Guangyuan Central Hospital

616156797@qq.com+86 15983921651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026